BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GENpathway Inc. Launches Next-Generation Tools For Analyzing Gene Transcription, Regulation And Corresponding Genetic Pathways


10/19/2005 5:12:56 PM

SAN DIEGO, March 4 /PRNewswire/ -- Genpathway, Inc. today announced the availability of its novel tools enabling discovery and characterization of differential gene transcription, components and processes for gene regulation, and corresponding genetic pathways.

In contrast to RNA profiling methods, Genpathway's tools measure the process of transcription rather than the product of the process (RNA). These innovative tools -- TranscriptionPath(TM), FactorPath(TM) and PromoterPath(TM) -- provide knowledge about changes in gene expression and regulation with greater accuracy and reproducibility, and generate information that is unattainable using other available technologies.

"Scientists use RNA profiling to measure accumulated levels of RNA. They also see substantial added value in tools that measure the actual transcription of genes -- including the relative levels at which genes are being expressed -- and tools that generate a more accurate picture of differential gene activation and repression. Genpathway provides these tools," said Mary Warren, Chief Scientific Officer of Genpathway. "RNA profiling faces challenges because RNA is relatively unstable, the data analysis is difficult, and determining which genes are coordinately regulated can only be done by inference. Genpathway's new tools go beyond RNA profiling but can also be used to clarify or verify RNA profiling results."

"When studying changes in gene expression, I would rather measure transcription directly than accumulated levels of RNA," said James Kadonaga, Chairman of Molecular Biology at the University of California, San Diego. "Genpathway's TranscriptionPath(TM) provides insight into changes in gene expression that could not be obtained by conventional microarray analysis. These tools are particularly useful to anyone who wants to identify or characterize genes that are activated or repressed upon treatment with a stimulus, such as a drug."

  Genpathway's proprietary tools include:

   -- TranscriptionPath(TM): Identification and quantitation of gene
      transcription based on isolation and characterization of
      DNA/transcription machinery complexes.

   -- FactorPath(TM): Discovery and quantitation of binding by transcription
      factors and coactivators.

   -- PromoterPath(TM): Identification of promoters and enhancers, and
      quantitation of their use.

  Genpathway offers two informative modes of analysis for each tool:

   -- QueryMode(TM): Investigates specific genes or genomic regions for
      transcription or protein binding.

   -- DiscoveryMode(TM): Scans across the genome for all sequences involved
      in transcription or gene regulation.

  ABOUT GENPATHWAY, INC.

Genpathway is a systems biology company developing innovative tools that identify and analyze complex biological pathways to drive discovery and testing of novel pharmaceuticals, biomarkers and diagnostic tests. http://www.genpathway.com/

CONTACT: Mary Moynihan M2Friend Communications 802 951 9600 mary@m2friend.com

Genpathway, Inc.

CONTACT: Mary Moynihan of M2Friend Communications, +1-802-951-9600,mary@m2friend.com, for Genpathway, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES